The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies
{{output}}
Chronic lymphocytic leukemia (CLL) is an indolent but incurable disease. Despite the improvement of the available therapies, the management of heavily-treated CLL patients represents a challenge for modern practitioners. Ofatumumab is a second-generation, full... ...
